51 Biggest Movers From Yesterday



  • Sunshine Biopharma, Inc. SBFM shares surged 148.2% to close at $5.61 on Tuesday after the company announced that two of its designed mRNA molecules are effective at destroying cancer cells grown in culture.
  • Anghami Inc. ANGH gained 47.5% to close at $13.41.
  • Dingdong (Cayman) Limited DDL shares jumped 46% to close at $6.86.
  • Inozyme Pharma, Inc. INZY surged 38.6% to close at $5.96 after the company announced preliminary data from its Phase 1/2 trial of INZ-701 in patients with ENPP1 deficiency.
  • Tantech Holdings Ltd TANH gained 31.3% to close at $0.6655.
  • Kaspien Holdings Inc. KSPN jumped 28.9% to close at $9.50.
  • Celsion Corporation CLSN rose 26.4% to close at $6.22 after Zack's Small Cap Research and Brookline set bullish price targets on the stock.
  • BT Brands, Inc. BTBD gained 25.5% to settle at $3.10.
  • FG Financial Group, Inc. FGF jumped 24.4% to settle at $3.5950 following a 13G filing from Peter Lynch showing a new 5.83% stake in the company
  • System1, Inc. SST gained 23% to settle at $20.31 as the company reported a 48% year-over-year surge in Q4 sales and issued strong sales forecast.
  • Spirit Airlines, Inc. SAVE jumped 22.4% to close at $26.92 following an NYT report suggesting JetBlue has made a $3.6 billion offer for the company.
  • Helix Acquisition Corp. HLXA gained 19.8% to close at $13.25.
  • Energy Vault Holdings, Inc. NRGV jumped 18.9% to close at $21.64.
  • Ensysce Biosciences, Inc. ENSC climbed 18.8% to close at $1.33. Ensysce Biosciences recently posted a Q4 loss of $0.45 per share.
  • BigBear.ai Holdings, Inc. BBAI gained 18.3% to close at $10.34.
  • Sphere 3D Corp ANY gained 16.6% to settle at $2.53. Sphere 3D and Gryphon Digital Mining 'plan to continue working on existing strategic initiatives, including the management of Sphere 3D's 6.0 EH/s mining fleet' following mutual agreement not to move forward with merger.
  • Nam Tai Property Inc. NTP climbed 16.4% to close at $7.33.
  • Compass Therapeutics, Inc. CMPX gained 16.3% to close at $1.86.
  • Bone Biologics Corporation BBLG surged 16% to close at $3.04.
  • CNS Pharmaceuticals, Inc. CNSP gained 14.7% to close at $0.3797. CNS Pharmaceuticals received approval from Competent Authority of Switzerland for potentially pivotal study of berubicin for treatment of glioblastoma multiforme.
  • Worksport Ltd. WKSP jumped 13.6% to close at $3.25.
  • Singularity Future Technology Ltd. SGLY jumped 13.6% to close at $17.00.
  • Recon Technology, Ltd. RCON gained 11.2% to close at $1.19 following 13D filing from co-founder, Shenping Yin, showing raised stake in the company from 12% to 50%.
  • Allego N.V. ALLG gained 10.6% to close at $13.40.
  • Asure Software, Inc. ASUR climbed 8.5% to close at $6.74.
  • Arcus Biosciences, Inc. RCUS climbed 8.1% to settle at $37.73. Arcus Biosciences will replace Investors Bancorp in the S&P SmallCap 600 effective Thursday, April 7.
  • Lucira Health, Inc. LHDX gained 6.9% to close at $3.90.

Don’t forget to check out our premarket coverage here .


  • Nutex Health Inc. NUTX shares dipped 33.4% to close at $26.64 on Tuesday. Clinigence Holdings and Nutex Health, on Monday, reported completion of merger and listing on the Nasdaq Capital Market.
  • Cognyte Software Ltd. CGNT shares dipped 31.1% to close at $8.03 after the company reported worse-than-expected Q4 EPS and sales results.
  • IMARA Inc. IMRA shares fell 22.1% to close at $1.27 after the company said interim results in ardent trial for sickle cell disease showed no significant difference in median annualized rate of vaso-occlusive crises.
  • Immix Biopharma, Inc. IMMX dipped 22% to close at $2.02. The company’s management discussed key milestones, drug development timelines and the IMMX Advantage at its Milestone Day Event held on April 5, 2022.
  • Zosano Pharma Corporation ZSAN fell 20.3% to close at $0.1610. Zosano Pharma recently said it is looking at strategic alternatives and reduced 31% of its staff as the FDA rejected its already-rejected migraine drug last month.
  • Cassava Sciences, Inc. SAVA dropped 18.8% to close at $31.23.
  • Integrated Media Technology Limited IMTE fell 18.4% to $29.06.
  • GWG Holdings, Inc. GWGH fell 17.1% to close at $3.50.
  • C4 Therapeutics, Inc. CCCC dipped 16.8% to close at $22.00.
  • Precipio, Inc. PRPO fell 16.7% to close at $1.40 after surging around 22% on Monday.
  • Castle Biosciences, Inc. CSTL dropped 16.5% to close at $38.40. Castle Biosciences agreed to acquire AltheaDx Inc, a commercial-stage molecular diagnostics company, for $140 million, including milestone payment.
  • Digital World Acquisition Corp. DWAC fell 15.7% to close at $48.00 amid Elon Musk taking a 9.2% stake in competitor Twitter.
  • BRC Inc. BRCC dipped 14.8% to close at $24.10 after Raymond James downgraded the stock from Outperform to Market Perform.
  • SAB Biotherapeutics, Inc. SABS dropped 13.8% to close at $2.81.
  • Dolphin Entertainment, Inc. DLPN fell 13.6% to close at $4.69.
  • Vivos Therapeutics, Inc. VVOS fell 12.8% to close at $1.83. Vivos Therapeutics recently posted Q4 sales of $4.40 million.
  • Direct Digital Holdings, Inc. DRCT declined 12.5% to close at $3.21.
  • Takung Art Co., Ltd. TKAT dropped 11.8% to close at $3.44.
  • Xponential Fitness, Inc. XPOF shares fell 11.1% to close at $21.02 as the company reported a public offering of 4.5 million shares of the common stock by selling stockholders.
  • SmartRent, Inc. SMRT dipped 10.9% to close at $4.81.
  • GameStop Corp. GME dropped 10% to close at $153.59.
  • Carvana Co. CVNA dropped 8.7% to close at $121.46 as RBC Capital downgraded the stock from Outperform to Sector Perform and lowered its price target from $155 to $138.
  • Acuity Brands, Inc. AYI dropped 8.1% to close at $170.12 following Q2 results.
  • GBS Inc. GBS fell 7.6% to close at $1.21 after jumping 68% on Monday. Zacks Small-Cap Research, on Monday, issued a note on GBS with an $8 valuation.
Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasMovers From Yesterday
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!